Point-of-Care Tenofovir Urine Testing for the Prediction of Treatment Failure and Drug Resistance During Initial Treatment for Human Immunodeficiency Virus Type 1 (HIV-1) Infection

BACKGROUND: Viral rebound during antiretroviral treatment (ART) is most often driven by suboptimal adherence in the absence of drug resistance. We assessed the diagnostic performance of point-of-care (POC) tenofovir (TFV) detection in urine for the prediction of viral rebound and drug resistance dur...

Descripción completa

Detalles Bibliográficos
Autores principales: Hermans, Lucas E, Umunnakwe, Chijioke N, Lalla-Edward, Samanta T, Hebel, Shane K, Tempelman, Hugo A, Nijhuis, Monique, Venter, Willem D F, Wensing, Annemarie M J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9907515/
https://www.ncbi.nlm.nih.gov/pubmed/36136811
http://dx.doi.org/10.1093/cid/ciac755

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9907515/
https://www.ncbi.nlm.nih.gov/pubmed/36136811
http://dx.doi.org/10.1093/cid/ciac755

Ejemplares similares